Canada markets open in 1 hour 21 minutes

GenSight Biologics S.A. (GSGTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.45000.0000 (0.00%)
At close: 12:14PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 35.12M
Enterprise Value 51.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)17.86
Price/Book (mrq)41.46
Enterprise Value/Revenue 47.84
Enterprise Value/EBITDA -2.09

Trading Information

Stock Price History

Beta (5Y Monthly) 2.14
52-Week Change 3-85.48%
S&P500 52-Week Change 329.57%
52 Week High 33.1000
52 Week Low 30.0003
50-Day Moving Average 30.4660
200-Day Moving Average 30.6604

Share Statistics

Avg Vol (3 month) 312
Avg Vol (10 day) 375
Shares Outstanding 578.03M
Implied Shares Outstanding 684.18M
Float 831.85M
% Held by Insiders 111.83%
% Held by Institutions 113.95%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-629.34%

Management Effectiveness

Return on Assets (ttm)-71.79%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)3.33M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-36.10%
Gross Profit (ttm)N/A
EBITDA -32.83M
Net Income Avi to Common (ttm)-28.87M
Diluted EPS (ttm)-0.6800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.02M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)21.39M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.48
Book Value Per Share (mrq)-0.59

Cash Flow Statement

Operating Cash Flow (ttm)-33.27M
Levered Free Cash Flow (ttm)-21.8M